Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer
- Research works
- 23 fractional, all time
- Citations
- 90 3.9 per fractional work
- Top-10% rate
- 20.9% record average 16.5%
- Open access
- 73% world 28%
Not ranked overall: Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.7×. Every wedge is a field page.
- Medicine 3.7×
- Biochemistry, Genetics and Molecular Biology 3.1×
- Immunology and Microbiology 2.7×
- Health Professions 0.8×
- Psychology 0.7×
- Neuroscience 0.6×
- Decision Sciences 0.4×
- Nursing 0.3×
- Economics, Econometrics and Finance 0.3×
- Computer Science 0.2×
- Environmental Science 0.2×
- Chemistry 0.1×
- Social Sciences 0.1×
- Pharmacology, Toxicology and Pharmaceutics 0.1×
Which keywords describe research at Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Breast Cancer, Chemotherapy, Survival Analysis, Clinical Practice Guidelines, Lymphoma, Gene Expression and Neoadjuvant Therapy.
- Metastatic Breast Cancer
- Gene Expression
- Lymphoma
- Clinical Practice Guidelines
- Chemotherapy
- Breast Cancer
- Immunotherapy
- Epidemiology
- Survival Analysis
- Inflammation
- Cancer
- Neoadjuvant Therapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 12 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 12 words, with their numbers
- Immunotherapy2▲ 11×7 topics
- Breast Cancer2▲ 31×4 topics
- Epidemiology2▲ 1.92×19 topics
- Chemotherapy1▲ 9.7×9 topics
- Survival Analysis1▲ 22×4 topics
- Clinical Practice Guidelines1▲ 10×5 topics
- Inflammation1▲ 2.6×22 topics
- Lymphoma1▲ 34×2 topics
- Cancer1▲ 3.8×16 topics
- Gene Expression1▲ 8.4×7 topics
- Neoadjuvant Therapy1▲ 21×3 topics
- Metastatic Breast Cancer1▲ 83×2 topics
Which research topics does Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies and Renal Transplantation Outcomes and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 1 works
- 2 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
- 3 Breast Cancer Treatment Studies Cancer Research 1 works
- 4 Renal Transplantation Outcomes and Treatments Transplantation 0 works
- 5 Liver Disease Diagnosis and Treatment Epidemiology 0 works
- 6 Cancer Genomics and Diagnostics Cancer Research 0 works
- 7 HER2/EGFR in Cancer Research Oncology 0 works
- 8 Acute Myeloid Leukemia Research Hematology 0 works
- 9 Chronic Lymphocytic Leukemia Research Genetics 0 works
- 10 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
Other research institutions in Barcelona
- Universitat de Barcelona
- Universitat Politècnica de Catalunya
- Universitat Pompeu Fabra
- Hospital Clínic de Barcelona
- Vall d'Hebron Hospital Universitari
- Hospital de Sant Pau
- Universitat Oberta de Catalunya
- Institució Catalana de Recerca i Estudis Avançats
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.